SCHEMBL20391815

SCHEMBL20391815

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc(-c4ccc5oc6cccc(-c7nc(-c8ccccc8)cc(-c8ccccc8)n7)c6c5c4)cc3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.41
PLA2G4A P47712 4/20 0.41
PLA2G10 O15496 1/20 0.41
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 4/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
NTSR1 P30989 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GAA P10253 1/20 0.38
PRKDC P78527 1/20 0.37
GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24216391 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL20391913 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL20391917 0.99 MEN1 (0.41) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL19802527 0.99 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL19802431 0.99 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL19802529 0.99 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL20391808 0.99 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL26707754 0.97 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL19802438 0.97 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL22329231 0.95 MEN1 (0.46) PLA2G2APLA2G4APLA2G10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023355-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-01-18 US disclosed
US-20240023355-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-01-18 US disclosed
US-11800730-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-10-24 US disclosed
US-11800730-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-10-24 US disclosed
US-11685859-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-06-27 US disclosed
US-11685859-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-06-27 US disclosed
US-20210009894-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2021-01-14 US disclosed
EP-3348625-A1 ORGANIC LIGHT-EMITTING DEVICE LG Chem, Ltd. (KR) 2018-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023355-A1 ORGANIC LIGHT EMITTING DEVICE CRY1, CRY2, CYP1A1 PLA2G2A 2723/4885PLA2G4A 3014/4885PLA2G10 3509/4885
US-11800730-B2 Organic light emitting device CRY1, CRY2, MAP1LC3C PLA2G2A 1705/4885PLA2G4A 2120/4885PLA2G10 3644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.